Form 4: Amneal Pharmaceuticals Director John Kiely Disposes of Shares Following Vesting of Restricted Stock Units

Director John Kiely disposed of 76,453 shares of Amneal Pharmaceuticals Class A Common Stock on May 10, 2024, following the vesting of restricted stock units.

Summary

• On May 10, 2024, John Kiely, a director of Amneal Pharmaceuticals, disposed of 76,453 shares of Class A Common Stock.
• This transaction occurred following the vesting of 76,453 restricted stock units granted on May 9, 2023, which vested on May 10, 2024.
• After the transaction, Kiely directly owns 255,727 shares of Amneal Pharmaceuticals Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider trading activity related to stock options vesting. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding more than 10% of a company's shares) trade in their company's stock; this provides transparency to the market.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership by a company director.
• The disposal of shares by a director could be perceived negatively by some investors, although it is a common occurrence after vesting of stock options.

Key Dates